Results
Experts Jury survey results of 2018 in category
Antiviral medications / The drug for preventing and treating colds and flu
1. Гропринозин (Gedeon Richter)Link 40.00% 5
 
2. Аміксин IC (InterChem)Link 30.00% 3.75
 
2. Анаферон (Materia Medica – Ukraine)Link 30.00% 3.75
 
4. Amizon (Farmak)Link 20.00% 2.50
 
4.
~
Immunoflazid (Ecofarm)Link 20.00% 2.50
 
4. Viferon (Feron)Link 20.00% 2.50
 
4. Афлубін (Perrigo)Link 20.00% 2.50
 
4.
~
Колдрекс (GlaxoSmithKline)Link 20.00% 2.50
 
4.
~
Оксолінова мазь (Nizhpharm)Link 20.00% 2.50
 
4.
~
Ремавір (Олайнфарм)Link 20.00% 2.50
 
4.
3
Фармацитрон (Pharmascience)Link 20.00% 2.50
 
12.
4
Ergoferon (Materia Medica – Ukraine)Link 10.00% 1.25
 
12.
~
Influcid (DHU)Link 10.00% 1.25
 
12.
4
Грип-Хеель (Heel) 10.00% 1.25
 
12.
3
Енгістол (Heel)Link 10.00% 1.25
 
12.
~
Ехінацея-Фаркос (Фаркос)Link 10.00% 1.25
 
12.
4
Кагоцел (Ніармедик Плюс) 10.00% 1.25
 
12.
4
Комбігрип (Синмедик Лабораторіз) 10.00% 1.25
 
12.
~
Лавомакс (Nizhpharm)Link 10.00% 1.25
 
12.
~
Пертуссин (Ternopharm) 10.00% 1.25
 
12.
~
Терафлю (Novartis OTC)Link 10.00% 1.25
 
12.
4
Фервекс (Bristol-Myers Squibb)Link 10.00% 1.25
 
12.
3
Хелпекс (Movi Health GmbH)Link 10.00% 1.25
 
–.
~
Солодки корня сироп (Ternopharm)Link 10.00% 1.25
 
View results of current, 2024 year  Show all preparations

Normed consumer's score are calculated by 5-score scale, accordingly to the methodic of the research.
Notice
The participant which took the 1st place in this rating is by opinion of industry specialists is the best choice in 2018, recommendation of an experts #1 in the category “The drug for preventing and treating colds and flu”.
Using this rating is only possible with obligatory link to the source.
This rating was built as a result of the study of social preferences in 2018, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.  Details…
Comments(39)
all in a row | positive | negative

No negative comments yet… Be the first to leave comment on this topic!

or
You may sign in using:
Enter with Facebook Enter with Google Enter with VK
Aye Nay
  

Achtung! Please be polite! Although that modertors of this web-portal are excessively democratic, any unethical, unqotable or just rude expressions, which abuse other visitors of this web site, can be deleted. Also will be deleted any spam and public comments with private phone numbers.